Suppr超能文献

在小鼠模型中,微塑料通过改变肠道微生物群和代谢物来影响砷的生物有效性。

Microplastics affect arsenic bioavailability by altering gut microbiota and metabolites in a mouse model.

作者信息

Chen Shan, Yang Jin-Lei, Zhang Yao-Sheng, Wang Hong-Yu, Lin Xin-Ying, Xue Rong-Yue, Li Meng-Ya, Li Shi-Wei, Juhasz Albert L, Ma Lena Q, Zhou Dong-Mei, Li Hong-Bo

机构信息

State Key Laboratory of Pollution Control and Resource Reuse, Jiangsu Key Laboratory of Vehicle Emissions Control, School of the Environment, Nanjing University, Nanjing, 210023, China.

Jiangsu Province Engineering Research Center of Soil and Groundwater Pollution Prevention and Control, Jiangsu Provincial Academy of Environmental Science, Nanjing, 210036, China.

出版信息

Environ Pollut. 2023 May 1;324:121376. doi: 10.1016/j.envpol.2023.121376. Epub 2023 Feb 28.

Abstract

Microplastics exposure is a new human health crisis. Although progress in understanding health effects of microplastic exposure has been made, microplastic impacts on absorption of co-exposure toxic pollutants such as arsenic (As), i.e., oral bioavailability, remain unclear. Microplastic ingestion may interfere As biotransformation, gut microbiota, and/or gut metabolites, thereby affecting As oral bioavailability. Here, mice were exposed to arsenate (6 μg As g) alone and in combination with polyethylene particles of 30 and 200 μm (PE-30 and PE-200 having surface area of 2.17 × 10 and 3.23 × 10 cm g) in diet (2, 20, and 200 μg PE g) to determine the influence of microplastic co-ingestion on arsenic (As) oral bioavailability. By determining the percentage of cumulative As consumption recovered in urine of mice, As oral bioavailability increased significantly (P < 0.05) from 72.0 ± 5.41% to 89.7 ± 6.33% with PE-30 at 200 μg PE g rather than with PE-200 at 2, 20, and 200 μg PE g (58.5 ± 19.0%, 72.3 ± 6.28%, and 69.2 ± 17.8%). Both PE-30 and PE-200 exerted limited effects on pre- and post-absorption As biotransformation in intestinal content, intestine tissue, feces, and urine. They affected gut microbiota dose-dependently, with lower exposure concentrations having more pronounced effects. Consistent with the PE-30-specific As oral bioavailability increase, PE exposure significantly up-regulated gut metabolite expression, and PE-30 exerted greater effects than PE-200, suggesting that gut metabolite changes may contribute to As oral bioavailability increase. This was supported by 1.58-4.07-fold higher As solubility in the presence of up-regulated metabolites (e.g., amino acid derivatives, organic acids, and pyrimidines and purines) in the intestinal tract assessed by an in vitro assay. Our results suggested that microplastic exposure especially smaller particles may exacerbate the oral bioavailability of As, providing a new angle to understand health effects of microplastics.

摘要

微塑料暴露是一场新的人类健康危机。尽管在了解微塑料暴露对健康的影响方面已取得进展,但微塑料对同时暴露的有毒污染物(如砷)吸收的影响,即口服生物利用度,仍不清楚。摄入微塑料可能会干扰砷的生物转化、肠道微生物群和/或肠道代谢物,从而影响砷的口服生物利用度。在此,将小鼠单独暴露于砷酸盐(6μg As/g)以及与饮食中2、20和200μg PE/g的30μm和200μm聚乙烯颗粒(PE-30和PE-200,表面积分别为2.17×10和3.23×10cm²/g)共同暴露,以确定同时摄入微塑料对砷口服生物利用度的影响。通过测定小鼠尿液中回收的累积砷消耗量的百分比,当PE-30为200μg PE/g时,砷的口服生物利用度从72.0±5.41%显著增加(P<0.05)至89.7±6.33%,而PE-200在2、20和200μg PE/g时(分别为58.5±19.0%、72.3±6.28%和69.2±17.8%)则未出现这种情况。PE-30和PE-200对肠道内容物、肠组织、粪便和尿液中吸收前和吸收后的砷生物转化均影响有限。它们对肠道微生物群的影响具有剂量依赖性,较低的暴露浓度影响更为显著。与PE-30特异性增加砷的口服生物利用度一致,PE暴露显著上调肠道代谢物表达,且PE-30的影响大于PE-200,这表明肠道代谢物变化可能有助于砷口服生物利用度的增加。体外试验评估显示,在肠道中上调代谢物(如氨基酸衍生物、有机酸以及嘧啶和嘌呤)存在的情况下,砷的溶解度提高了1.58至4.07倍,这支持了上述观点。我们的结果表明,微塑料暴露尤其是较小颗粒可能会加剧砷的口服生物利用度,为理解微塑料对健康的影响提供了一个新视角。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验